Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 130 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1291 9.5 months Advanced ovarian cancer 4 Biologic therapy
Chemotherapy
Indiana University School of Medicine United States 8/2008
Treatment Details: Patients: This study involved 23 women with advanced, platinum-resistant ovarian cancer and primary peritoneal carcinoma. The median age was 56, ranging from 33 to 76 years of age. Tr
 
1292 9.4 months Advanced NSCLC 5 Chemotherapy
University General Hospital of Heraklion Greece 1/2008
Treatment Details: Patients: This study involved 322 patients with advanced non-small cell lung cancer. The majority of patients were male smokers, and they ranged in age from 33 to 78 years old. Treatmen
 
1293 9.4 months Melanoma 5 Chemotherapy
University of Nottingham United Kingdom 5/2011
Treatment Details: Patients: This phase III study involved stage IV melanoma patients who were divided into two separate treatment groups. Group A included 429 patients, 64% of whom were over the age of 65 y
 
1294 9.4 months Hormone-refractory metastatic prostate cancer 4 Chemotherapy
Leon Berard France 8/2003
Treatment Details: Patients: This Phase II randomized study involved 54 patients with hormone refractory metastatic prostate cancer. Patients were divided into two groups: Group 1 with 26 patients and Group 2
 
1295 9.4 months Recurrent GBM 4 Chemotherapy
Dokkyo University School of Medicine, Mibu, Japan 12/2002
Treatment Details: Patients: A total of 28 patients were enrolled in this Phase II study. There were fourteen anaplastic astrocytoma patients whose tumors have recurred and fourteen patients with recurring gl
 
1296 9.4 months Malignant Pleural Mesothelioma 4 Chemotherapy
University Hospital Rotterdam Netherlands 2/2002
Treatment Details: Patients: This Phase II trial involved 32 patients with malignant pleural mesothelioma. None of these patients had received prior chemotherapy. Treatment: The treatment consisted of two
 
1297 9.4 months Advanced or metastatic breast cancer 4 Churchill Hospital United Kingdom 5/2002
Treatment Details: Patients: This Phase II study involved 44 women with advanced and/or metastatic breast cancer. Most patients had been treated previously with other regimens. Patients were divided into two
 
1298 9.4 months SCLC 5 Chemotherapy
S.G. Moscati Hospital Italy 5/2012
Treatment Details: Patients: This study involved small-cell lung cancer patients who were divided into two separate treatment groups. Group A had 328 patients with a median age of 67 years and 77.7% male. G
 
1299 9.4 months Recurrent GBM 5 Biologic therapy
National Cancer Institute, National Institutes of Health United States 1/2013
Treatment Details: Patients: This phase 2 study involved recurrent glioblastoma patients who were divided into two separate patient groups. Group A consisted of 32 patients with a median age of 57 years who
 
1300 9.4 months Advanced triple-negative breast cancer 5 Biologic therapy
Istituto Europeo di Oncologia Italy 10/2013
Treatment Details: Patients: This phase 2 study involved 113 previously treated advanced triple-negative breast cancer patients. The median patient age was 52 years. Treatment: Patients were treated with
 
Page 130 of 187  | Previous Page  | Next Page